Abstract

Objective To observe the change of intracranial pressure in the treatment of hypertensive intracerebral hemorrhage (HICH) by observing continuous intracranial pressure (ICP), to guide the application and adjustment of dehydrating agent, to analyze the clinical curative effect and evaluate its clinical application value. Methods 86 patients with hypertensive intracerebral hemorrhage (HICH) were enrolled in this study from June 2014 to June 2016. The patients were randomly divided into two groups according to the digital table method. 43 patients in the control group were treated with basic therapy and mannitol; 43 patients in the observation group received intracranial pressure monitoring on the basis of the control group, adjusting mannitol dosage and treatment options in accordance with the changes of monitoring data. And the clinical effect of the two groups were compared. Results After 6 months of treatment, the good rate of the observation group was 58.14%, and significantly higher than 32.56% of the control group (χ2=5.6770, P<0.05). The average total amount of mannitol in the observation group was significantly lower than that in the control group (P<0.05). The incidences of electrolyte imbalance, pulmonary infection, renal dysfunction, stress ulcer, and recurrent cerebral hemorrhage in the observation group in the duration of hospital stay were significantly lower than those in the control group (P<0.05). Conclusion In patients with HICH, continuous ICP monitoring can effectively guide the flexible use of dehydrating agent, significantly reduce the incidence of complications, significantly improve the prognosis, which has become a more ideal adjuvant therapy in the cerebral surgery. Key words: Hypertensive intracerebral hemorrhage; Continuous intracranial pressure monitoring; Treatment

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call